Help us: Donate
Follow us on:
×

Menu

Back

Long Non-Coding RNAs as an Alternative to Senolytics

Affecting these RNAs directly might one day be a better option than exterminating senescent cells.

RNA strandRNA strand
 

New research has identified a set of long noncoding RNAs involved in inflammaging and the senescence-associated secretory phenotype (SASP) [1]. These RNAs are conserved across a range of species, including humans, and may prove a valuable avenue for controlling senescence.

Age-related RNAs

RNA can broadly be divided into protein-coding RNAs and noncoding RNAs, which have multiple different types and functions. Some have been known for a long time, while others have been discovered more recently and are less well understood. Noncoding RNAs longer than 200 nucleotides are called long noncoding RNAs (lncRNAs). A significant proportion of lncRNAs seem to be evolutionarily conserved and differentially expressed in specific cell types, but their functions are generally unknown.

To identify lncRNAs that might be involved in aging, Donghong Cai and Jing-Dong Han of the Chinese Academy of Sciences and Peking University analyzed publicly available RNA sequencing data from eleven species at different ages. The species included humans, a couple of other primates, rats, pigs, wolves, two fish, fruit flies, and nematodes. They report that protein-coding RNAs usually had more age-dependent expression than lncRNAs. However, to their surprise, they found that lncRNAs associated with aging were more strongly evolutionarily conserved than other lncRNAs.

Figuring out function

The researchers used a “guilt-by-association” approach to determine the function of these lncRNAs. That is, their function was inferred based on their coexpression with protein-coding RNAs in specific tissues. Based on this, they found that the function of lncRNAs that were downregulated with age differed between tissues, but a set of 13 lncRNAs upregulated across a range of tissues were involved in regulating the NFκB pathway. The duo dubbed these “NFκB modulating aging-related lncRNAs”, giving them the impressive acronym NFKBMARLs.

Further work on one of these, NFKBMARL-1, showed that it is upregulated during inflammation and senescence in response to NFκB. However,  NFKBMARL-1 also activates NFκB by controlling the expression of NFKBIZ, a regulator of NFκB involved in the SASP. The combination of the two regulatory relationships links  NFKBMARL-1 and NFκB in a positive feedback loop, though the precise dynamics await further exploration.

Activation of NFκB is a key component of the SASP. NFKBMARL-1 thus regulates the SASP via its effect on NFκB, but it may not affect senescence more generally, since senescence and the SASP are independently regulated. If so, then NFKBMARL-1 or some of the other lncRNAs identified in this study may offer a viable avenue for senomorphic therapies which, unlike senolytics, aim to modulate the SASP while leaving the beneficial effects of senescence intact.

The transcriptome undergoes global changes during aging, including both protein-coding and noncoding RNAs. Using comparative genomics, we identify aging-associated long noncoding RNAs (lncRNAs) that are under evolutionary constraint and are more conserved than lncRNAs that do not change with age. Aging-associated lncRNAs are enriched for functional elements, including binding sites for RNA-binding proteins and transcription factors, in particular nuclear factor kappa B (NFκB). Using CRISPR screening, we discovered that 13 of the aging-associated lncRNAs were regulators of the NFκB pathway, and we named this family ‘NFκB modulating aging-related lncRNAs (NFKBMARLs)’. Further characterization of NFκBMARL-1 reveals it can be traced to 29 Ma before humans and is induced by NFκB during aging, inflammation and senescence. Reciprocally, NFκBMARL-1 directly regulates transcription of the NFκB inhibitor NFKBIZ in cis within the same topologically associated domain by binding to the NFKBIZ enhancer and recruiting RELA to the NFKBIZ promoter. These findings reveal many aging-associated lncRNAs are evolutionarily conserved components of the NFκB pathway.

Conclusion

It’s far too early to say how valuable this work is or will be. If these lncRNAs offer an effective way to decouple the SASP and senescence, they may prove to be clinically valuable tools for longevity interventions. Even if that’s not the case, the identification of a set of age-related regulatory RNAs that are conserved across such a wide range of species seems like an invaluable resource for future research. Whether that is the case, and what the fruits of that research will be, only time can tell.

HELP SPREAD THE WORD
Please connect with us on social media, like and share our content, and help us build grass-roots support for healthy life extension:
Lifespan.io YouTube
Lifespan.io Facebook
Lifespan.io Twitter
Lifespan.io Instagram
Lifespan.io Instagram
Lifespan.io Discord
Thank You!

Literature

[1] Cai, D and Han, JDJ. Aging-associated lncRNAs are evolutionarily conserved and participate in NFκB signaling. Nature Aging (2021), doi: 10.1038/s43587-021-00056-0
About the author
Sedeer el-Showk

Sedeer el-Showk

Sedeer became a professional science writer after finishing a degree in biology. He also writes poetry and sff, and somehow juggles an ever-growing list of hobbies from programming to knitting to gardening. Eternal curiosity and good fortune have taken him to many parts of the world, but he’s settled in Helsinki, Finland for the moment. He hopes he’ll never stop learning new things.
  1. 8080abc
    May 30, 2021

    Note the miRNAs, they correspond to gene expression. Some miRNAs circulate in the synovial fluid and their number decreases with age. This could be a system of messages from the hypothalamus which genes need to be activated.

  2. nsogoloff
    June 2, 2021

    i enjoy reading your article and although i am a young 80 years of age i am sure aging may be a thing of the past in five to ten years. i am looking forwarf to taking something to increase lifespan and healthspan.

Write a comment:

*

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

You have 3 free articles remaining this week. You can register for free to continue enjoying the best in rejuvenation biotechnology news. Already registered? Login here.